Difficulty: Medium
Average Score: 91%
Practice
Methylxanthines exert the following action(s) at cellular/molecular level
Correct answer
D
Rationale
Methylxanthines, like theophylline and caffeine, exert their pharmacological actions through multiple mechanisms at the cellular and molecular levels. The correct answer is D) All of the above.
A) Intracellular release of Ca┬▓Ôü║: Methylxanthines promote the release of intracellular calcium ions, which can lead to smooth muscle relaxation in the bronchioles, resulting in bronchodilation.
B) Antagonism of adenosine: Methylxanthines antagonize adenosine receptors, particularly the A1 and A2 receptors. Adenosine is a bronchoconstrictor, so by blocking its action, methylxanthines promote bronchodilation.
C) Inhibition of phosphodiesterase: Methylxanthines inhibit phosphodiesterase enzymes, especially phosphodiesterase type III and IV. By inhibiting these enzymes, they prevent the breakdown of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation and bronchodilation.
Educational context: Understanding the mechanisms of action of methylxanthines is crucial in pharmacology, particularly in the treatment of respiratory conditions like asthma and COPD. By knowing how methylxanthines work at the cellular and molecular levels, healthcare professionals can make informed decisions about their use, potential side effects, and drug interactions. This knowledge is essential for safe and effective medication management in patients with respiratory disorders.
A) Intracellular release of Ca┬▓Ôü║: Methylxanthines promote the release of intracellular calcium ions, which can lead to smooth muscle relaxation in the bronchioles, resulting in bronchodilation.
B) Antagonism of adenosine: Methylxanthines antagonize adenosine receptors, particularly the A1 and A2 receptors. Adenosine is a bronchoconstrictor, so by blocking its action, methylxanthines promote bronchodilation.
C) Inhibition of phosphodiesterase: Methylxanthines inhibit phosphodiesterase enzymes, especially phosphodiesterase type III and IV. By inhibiting these enzymes, they prevent the breakdown of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation and bronchodilation.
Educational context: Understanding the mechanisms of action of methylxanthines is crucial in pharmacology, particularly in the treatment of respiratory conditions like asthma and COPD. By knowing how methylxanthines work at the cellular and molecular levels, healthcare professionals can make informed decisions about their use, potential side effects, and drug interactions. This knowledge is essential for safe and effective medication management in patients with respiratory disorders.